Byeong-Keuk Kim Journalist Profile

Articles

[email protected] Byeong-Keuk Kim

Sep 3, 2024 | octnews.org | Byeong-Keuk Kim

September 3, 2024 | Cardiology | Chung-Ang University, Chungnam National University Hospital, Inje University, Korea University, Pusan National University, Sungkyunkwan University School of Medicine, Yonsei University Background Despite the detailed imaging information provided by optical coherence tomography (OCT) during percutaneous coronary intervention (PCI), clinical benefits of this imaging technique in this setting remain uncertain.
ESC 24: OCCUPI: OCT-Guided Coronary Intervention in Complex Lesions

Sep 2, 2024 | radcliffecardiology.com | Byeong-Keuk Kim |Harriette Van Spall |Scott Solomon |Jacob Lønborg

ESC Congress 24 — OCCUPI trial finds OCT-guided PCI more effective than angiography-guided PCI in reducing heart-related events.
ESC 24: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Sep 2, 2024 | radcliffecardiology.com | Byeong-Keuk Kim |Harriette Van Spall |Mirvat Alasnag |Scott Solomon

ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice. Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.
OCCUPI: OCT-Guided PCI vs. Angiography-Guided PCI in Patients Requiring DES For Complex Lesions

Aug 28, 2024 | acc.org | Byeong-Keuk Kim

ACC News Story Font Size A A A Optical coherence tomography (OCT) guidance during PCI resulted in a lower incidence of major adverse cardiac events at one year in patients requiring drug-eluting stent (DES) implantation for complex lesions, compared with angiography guidance, based on findings from the OCCUPI trial presented at ESC Congress 2024 in London and simultaneously published in The Lancet.
eClinicalMedicine, October 2023, Volume 64

Oct 24, 2023 | thelancet.com | Byeong-Keuk Kim

Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes
Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

Jul 10, 2023 | classic.clinicaltrials.gov | Byeong-Keuk Kim

Clopidogrel monotherapy has been found effective in reducing ischaemic cardiovascular and haemorrhagic complications in patients with drug-eluting stent (DES) placement. However, concerns remain about the safety of long-term clopidogrel monotherapy in high-risk patients with HPR (high platelet reactivity) who do not respond adequately to clopidogrel.
Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial - Full Text View - ClinicalTrials.gov

Mar 24, 2023 | clinicaltrials.gov | Byeong-Keuk Kim

This study sought to evaluate whether ezetimibe combination to high-intensity statin therapy will have more prominent beneficial effect compared to high-intensity statin monotherapy in patients who underwent coronary revascularization with newer generation drug-eluting stent (DES) implantation. Furthermore, the optimal OCT-based optimal expansion criteria as well as the efficacy and safety of newer generation will be investigated.
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial - Full Text View - ClinicalTrials

Jan 31, 2023 | clinicaltrials.gov | Byeong-Keuk Kim

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.